ACTRN12614001091695
Completed
未知
MumBubConnect: Effect of a text messaging service delivered to women with infants less than three months old on breastfeeding practices
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Breastfeeding
- Sponsor
- Queensland University of Technology
- Enrollment
- 120
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Women were eligible to participate if they were: over eighteen years of age; had an infant less than three months of age; were currently doing any breastfeeding ; did not have a diagnosed mental illness; and used a mobile phone (of any type).
Exclusion Criteria
- •Less than 18 years of age
- •Diagnosed mental illness
- •No mobile phone
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Evaluation of the effectiveness of an infant and family health and wellbeing text message intervention (Connecting 2u) in supporting expectant and new parentsParental attachmentMaternal ConfidenceParental Health BehavioursPublic Health - Health promotion/educationReproductive Health and Childbirth - Antenatal careReproductive Health and Childbirth - Childbirth and postnatal careACTRN12616000072415Children's Health Queensland1,200
Completed
Not Applicable
Can text message reminders improve participation in cervical cancer screening?Cervical cancer screeningCancerISRCTN10775349Taiwan Ministry of Science and Technology15,593
Completed
Not Applicable
Effect of text messaging program on lifestyle and clinical outcomes in patients with cardiovascular diseaseKCT0005087Inha University Hospital880
Active, not recruiting
Phase 4
Messaging Service for Patients with Type 2 Diabetes to support Insulin TitratioHealth Condition 1: E119- Type 2 diabetes mellitus without complicationsCTRI/2021/05/033506Roche Diabetes Care India Pvt Ltd
Completed
Not Applicable
Analysis of a messaging service to support patients with type 2 diabetes on basal insulin therapyType 2 diabetes mellitusNutritional, Metabolic, EndocrineISRCTN11911344Roche Diabetes Care GmbH30